{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:20:56Z","timestamp":1780539656804,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["bprch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.beha.2013.07.003","type":"journal-article","created":{"date-parts":[[2013,7,26]],"date-time":"2013-07-26T08:08:33Z","timestamp":1374826113000},"page":"171-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery"],"prefix":"10.1016","volume":"26","author":[{"given":"Daniel J.","family":"Quinlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt I.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2013.07.003_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1160\/TH10-10-0645","article-title":"Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database","volume":"105","author":"Guijarro","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib2","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.beha.2013.07.003_bib3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/jama.2011.2029","article-title":"Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review","volume":"307","author":"Januel","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.beha.2013.07.003_bib4","unstructured":"American Academy of Orthopaedic Surgeons. Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. Evidence-based guideline and evidence report. http:\/\/www.aaos.org\/research\/guidelines\/VTE\/VTE_full_guideline.pdf."},{"key":"10.1016\/j.beha.2013.07.003_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/030079907X242746","article-title":"Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty","volume":"24","author":"Friedman","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.beha.2013.07.003_bib6","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1538-7836.2010.03965.x","article-title":"A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty","volume":"8","author":"Dahl","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/jth.4900","article-title":"Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an ad hoc working group meeting","volume":"11","author":"Berger","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/0003088-200948010-00001","article-title":"Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor Xa inhibitors in development","volume":"48","author":"Eriksson","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.beha.2013.07.003_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","author":"Stangier","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.beha.2013.07.003_bib10","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/0091270009351883","article-title":"Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers","volume":"50","author":"Ogata","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.beha.2013.07.003_bib11","doi-asserted-by":"crossref","first-page":"e3675","DOI":"10.1136\/bmj.e3675","article-title":"Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons","volume":"344","author":"G\u00f3mez-Outes","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.beha.2013.07.003_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial","volume":"370","author":"Eriksson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2013.07.003_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1160\/TH10-10-0679","article-title":"Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial","volume":"105","author":"Eriksson","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib14","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial","volume":"5","author":"Eriksson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arth.2008.01.132","article-title":"Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery","volume":"24","author":"RE-MOBILIZE Writing Committee","year":"2009","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.beha.2013.07.003_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.thromres.2012.05.014","article-title":"Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2013.07.003_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-9560-10-9","article-title":"Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials","volume":"10","author":"Rosencher","year":"2012","journal-title":"Thromb J"},{"key":"10.1016\/j.beha.2013.07.003_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.thromres.2012.07.004","article-title":"Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2013.07.003_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.thromres.2012.08.315","article-title":"Efficacy of delayed thromboprophylaxis with dabigatran: pooled analysis","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2013.07.003_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-med-062209-095159","article-title":"Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism","volume":"62","author":"Eriksson","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.beha.2013.07.003_bib21","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.07.003_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)60880-6","article-title":"Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial","volume":"372","author":"Kakkar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2013.07.003_bib23","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1056\/NEJMoa076016","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty","volume":"358","author":"Lassen","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.07.003_bib24","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(09)60734-0","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial","volume":"373","author":"Turpie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2013.07.003_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH10-09-0601","article-title":"Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies","volume":"105","author":"Turpie","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/aas.12069","article-title":"Incidence of neuraxial haematoma after total hip or knee surgery: RECORD programme (rivaroxaban vs. enoxaparin)","volume":"57","author":"Rosencher","year":"2013","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.beha.2013.07.003_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1056\/NEJMoa0810773","article-title":"Apixaban or enoxaparin for thromboprophylaxis after knee replacement","volume":"361","author":"Lassen","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.07.003_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2013.07.003_bib29","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2013.07.003_bib30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/jth.12109","article-title":"Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups","volume":"11","author":"Pineo","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib31","first-page":"A20","article-title":"Edoxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty: the STARS E-3 trial (abstract)","volume":"37","author":"Fuji","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.beha.2013.07.003_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V116.21.3320.3320","article-title":"Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V trial (abstract)","volume":"116","author":"Fuji","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2013.07.003_bib33","first-page":"A95","article-title":"Safety and efficacy of edoxaban in patients undergoing hip fracture surgery (abstract)","volume":"37","author":"Fujita","year":"2010","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.beha.2013.07.003_bib34","series-title":"Summary of product characteristics, version 7","author":"Pradaxa","year":"2013"},{"key":"10.1016\/j.beha.2013.07.003_bib35","series-title":"Summary of product characteristics, version 5","author":"Xarelto","year":"2013"},{"key":"10.1016\/j.beha.2013.07.003_bib36","series-title":"US prescribing information, version","author":"Xarelto","year":"2013"},{"key":"10.1016\/j.beha.2013.07.003_bib37","series-title":"Summary of product characteristics, version 20","author":"Eliquis","year":"2012"},{"key":"10.1016\/j.beha.2013.07.003_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1160\/TH11-08-0589","article-title":"Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding","volume":"108","author":"Friedman","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.beha.2013.07.003_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.thromres.2011.12.005","article-title":"Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty","volume":"130","author":"Eriksson","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.beha.2013.07.003_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000102049","article-title":"Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty","volume":"35","author":"Dahl","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.beha.2013.07.003_bib41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/EJA.0b013e32833f6f6f","article-title":"Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology","volume":"27","author":"Gogarten","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.beha.2013.07.003_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.beha.2013.07.003_bib43","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/CIRCULATIONAHA.112.123224","article-title":"Periprocedural management and approach to bleeding in patients taking dabigatran","volume":"126","author":"Weitz","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.beha.2013.07.003_bib44","doi-asserted-by":"crossref","first-page":"c7270","DOI":"10.1136\/bmj.c7270","article-title":"New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty","volume":"342","author":"Eikelboom","year":"2011","journal-title":"BMJ"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692613000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T19:49:20Z","timestamp":1596224960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692613000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1521692613000248"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2013.07.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2013.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}